KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (NASDAQ: ABMC) announced today that they have launched the patent pending Rapid STAT, a new oral fluid point of collection test. The Company has already shipped its first orders of Rapid STAT to its S&P 500 laboratory alliance, and to its European master distributor for a government tender.
